Stocks Edge Higher Before FOMC Meeting Results

US equity markets are advancing, propelled by stronger-than-anticipated economic data, including a robust July ADP employment change and Q2 GDP expanding 3.0% annually. This economic resilience is driving gains, though investor focus remains on the impending FOMC meeting outcome and significant tech earnings from Microsoft and Meta Platforms post-market. Concurrently, the Treasury plans stable note and bond auction sizes, while former President Trump's tariff announcements, notably 25% on India, introduce trade policy uncertainty. Q2 S&P 500 earnings are exceeding expectations, tracking a 4.5% rise with 82% of reporting firms beating profit estimates.

Analysis

US equity markets are exhibiting cautious optimism, with major indices posting modest gains driven by signs of economic resilience. Specifically, the July ADP employment report surpassed expectations with a 104,000 increase, and Q2 GDP expanded at a stronger-than-anticipated 3.0% annualized rate. However, this economic strength is a double-edged sword, as the Q2 core PCE price index also rose more than expected to 2.5%, fueling concerns about persistent inflation and potentially influencing the Federal Reserve's policy stance. Consequently, 10-year Treasury yields have risen by 4.8 basis points to 4.368%, reflecting a repricing of monetary policy expectations. The market's advance is further restrained by anticipation of the FOMC meeting results and upcoming earnings reports from tech bellwethers Microsoft and Meta. The broader earnings season has been positive, with S&P 500 Q2 earnings tracking a 4.5% year-over-year increase, beating pre-season forecasts, and 82% of reporting firms surpassing profit estimates. This has created significant divergence in single-stock performance, with strong results from firms like Teradyne (TER, +18%) and Humana (HUM, +5%) being rewarded, while guidance cuts from companies like IDEX Corp (IEX, -9%) and weak forecasts from Seagate (STX) have led to sharp declines. Compounding the uncertainty is escalating trade policy risk, highlighted by a new 25% tariff announced for India and the looming August 1 deadline for broader trade deals.

Key Decisions for Investors

• Given the backdrop of strong Q2 earnings beats and resilient economic data, investors should favor companies demonstrating strong execution and positive forward guidance, such as Humana (HUM) and Teradyne (TER), while being cautious of firms issuing guidance cuts like IDEX Corp (IEX).
• Monitor the upcoming FOMC statement and Fed Chair Powell's commentary closely, as the stronger-than-expected GDP and core PCE data could prompt a more hawkish tone, potentially increasing bond yield pressure and equity market volatility.
• It is prudent to assess portfolio exposure to international trade risks, as the announced 25% tariff on India and broader threats of tariffs escalating to 15-50% could negatively impact companies with significant global supply chains or international sales.
• Note the weakness in the housing sector, evidenced by the unexpected 0.8% m/m decline in pending home sales, which contrasts with broader economic strength and may signal vulnerability in related industries.